KSS Kohl's | $25.04 +0.9% | 3/13/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $20.00 -> $21.00 | Low | View details for JPMorgan Chase & Co. rating of Kohl’s (NYSE:KSS) on 3/13/2024 |
CMS CMS Energy | $58.30 +0.8% | 3/13/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $65.00 -> $66.00 | Low | View details for JPMorgan Chase & Co. rating of CMS Energy (NYSE:CMS) on 3/13/2024 |
DTE DTE Energy | $109.48 +0.9% | 3/13/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $118.00 -> $120.00 | Low | View details for JPMorgan Chase & Co. rating of DTE Energy (NYSE:DTE) on 3/13/2024 |
ITRI Itron | $87.41 +0.5% | 3/13/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $77.00 -> $92.00 | Low | View details for JPMorgan Chase & Co. rating of Itron (NASDAQ:ITRI) on 3/13/2024 |
OKE ONEOK | $77.79 +1.0% | 3/13/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $81.00 -> $85.00 | Low | View details for JPMorgan Chase & Co. rating of ONEOK (NYSE:OKE) on 3/13/2024 |
USPH U.S. Physical Therapy | $106.97 +0.3% | 3/13/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $99.00 -> $117.00 | Low | View details for JPMorgan Chase & Co. rating of U.S. Physical Therapy (NYSE:USPH) on 3/13/2024 |
|
UHS Universal Health Services | $177.20 +1.9% | 3/13/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $144.00 -> $182.00 | Low | View details for JPMorgan Chase & Co. rating of Universal Health Services (NYSE:UHS) on 3/13/2024 |
VEEV Veeva Systems | $228.45 +0.6% | 3/13/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $183.00 -> $222.00 | Low | View details for JPMorgan Chase & Co. rating of Veeva Systems (NYSE:VEEV) on 3/13/2024 |
INNV InnovAge | $4.65 +8.4% | 3/13/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $7.00 -> $6.00 | Low | View details for JPMorgan Chase & Co. rating of InnovAge (NASDAQ:INNV) on 3/13/2024 |
XEL Xcel Energy | $52.04 +0.1% | 3/13/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $68.00 -> $59.00 | Low | View details for JPMorgan Chase & Co. rating of Xcel Energy (NASDAQ:XEL) on 3/13/2024 |
FLUT Flutter Entertainment | $214.49 -0.7% | 3/13/2024 | Upgraded by | JPMorgan Chase & Co. | - | Neutral -> Overweight | | Low | View details for JPMorgan Chase & Co. rating of Flutter Entertainment (NYSE:FLUT) on 3/13/2024 |
ADBE Adobe | $513.86 +4.3% | 3/15/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $600.00 -> $570.00 | Low | View details for JPMorgan Chase & Co. rating of Adobe (NASDAQ:ADBE) on 3/15/2024 |
COIN Coinbase Global | $239.62 -1.1% | 3/15/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $95.00 -> $150.00 | N/A | View details for JPMorgan Chase & Co. rating of Coinbase Global (NASDAQ:COIN) on 3/15/2024 |
LLY Eli Lilly and Company | $762.66 +1.1% | 3/15/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $775.00 -> $850.00 | Low | View details for JPMorgan Chase & Co. rating of Eli Lilly and Company (NYSE:LLY) on 3/15/2024 |
DOCS Doximity | $27.88
| 3/15/2024 | Target Raised by | JPMorgan Chase & Co. | - | Underweight -> Underweight | $22.00 -> $25.00 | Low | View details for JPMorgan Chase & Co. rating of Doximity (NASDAQ:DOCS) on 3/15/2024 |
EVH Evolent Health | $32.17 -1.5% | 3/15/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $53.00 -> $52.00 | Low | View details for JPMorgan Chase & Co. rating of Evolent Health (NYSE:EVH) on 3/15/2024 |
DRS Leonardo DRS | $21.55 -1.9% | 3/15/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $25.00 -> $24.00 | Low | View details for JPMorgan Chase & Co. rating of Leonardo DRS (NASDAQ:DRS) on 3/15/2024 |
SMAR Smartsheet | $38.65 +3.0% | 3/15/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $54.00 -> $50.00 | Low | View details for JPMorgan Chase & Co. rating of Smartsheet (NYSE:SMAR) on 3/15/2024 |
WCC WESCO International | $161.93 +1.1% | 3/15/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $180.00 -> $175.00 | Low | View details for JPMorgan Chase & Co. rating of WESCO International (NYSE:WCC) on 3/15/2024 |
FOLD Amicus Therapeutics | $11.58 +0.9% | 3/18/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $21.00 -> $19.00 | Low | View details for JPMorgan Chase & Co. rating of Amicus Therapeutics (NASDAQ:FOLD) on 3/18/2024 |
RARE Ultragenyx Pharmaceutical | $46.59 -1.6% | 3/18/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $88.00 -> $92.00 | Low | View details for JPMorgan Chase & Co. rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 3/18/2024 |
LEN Lennar | $156.61 +0.0% | 3/18/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $161.00 -> $157.00 | Low | View details for JPMorgan Chase & Co. rating of Lennar (NYSE:LEN) on 3/18/2024 |
NMRA Neumora Therapeutics | $14.16 -6.2% | 3/18/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $20.00 -> $22.00 | Low | View details for JPMorgan Chase & Co. rating of Neumora Therapeutics (NASDAQ:NMRA) on 3/18/2024 |
LAC Lithium Americas | $5.72 -11.6% | 3/18/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral | $5.50 -> $7.00 | Low | View details for JPMorgan Chase & Co. rating of Lithium Americas (NYSE:LAC) on 3/18/2024 |
M Macy's | $21.23 +0.2% | 3/18/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $23.00 -> $25.00 | Low | View details for JPMorgan Chase & Co. rating of Macy’s (NYSE:M) on 3/18/2024 |
ESAB ESAB | $102.29 +2.9% | 3/18/2024 | Upgraded by | JPMorgan Chase & Co. | - | Neutral -> Overweight | $111.00 -> $125.00 | Low | View details for JPMorgan Chase & Co. rating of ESAB (NYSE:ESAB) on 3/18/2024 |
TEX Terex | $58.83 -0.4% | 3/18/2024 | Downgraded by | JPMorgan Chase & Co. | - | Overweight -> Neutral | $63.00 | Low | View details for JPMorgan Chase & Co. rating of Terex (NYSE:TEX) on 3/18/2024 |
EVCM EverCommerce | $8.78 +3.9% | 3/15/2024 | Reiterated by | JPMorgan Chase & Co. | - | Neutral -> Underweight | $11.00 -> $10.00 | Low | View details for JPMorgan Chase & Co. rating of EverCommerce (NASDAQ:EVCM) on 3/15/2024 |
DLTR Dollar Tree | $127.25 -0.1% | 3/14/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $165.00 -> $144.00 | Low | View details for JPMorgan Chase & Co. rating of Dollar Tree (NASDAQ:DLTR) on 3/14/2024 |
PATH UiPath | $23.07 +1.4% | 3/14/2024 | Upgraded by | JPMorgan Chase & Co. | - | Neutral -> Overweight | $22.00 -> $28.00 | Low | View details for JPMorgan Chase & Co. rating of UiPath (NYSE:PATH) on 3/14/2024 |
ATD Alimentation Couche-Tard | C$80.86 -3.4% | 3/13/2024 | Target Lowered by | JPMorgan Chase & Co. | - | | C$80.00 -> C$79.00 | N/A | View details for JPMorgan Chase & Co. rating of Alimentation Couche-Tard (TSE:ATD) on 3/13/2024 |
NRDY Nerdy | $2.93 -2.3% | 3/11/2024 | Initiated by | JPMorgan Chase & Co. | - | Overweight | $5.00 | Low | View details for JPMorgan Chase & Co. rating of Nerdy (NYSE:NRDY) on 3/11/2024 |
COO Cooper Companies | $100.82 +0.1% | 3/13/2024 | Upgraded by | JPMorgan Chase & Co. | - | Neutral -> Overweight | $100.00 -> $120.00 | Low | View details for JPMorgan Chase & Co. rating of Cooper Companies (NASDAQ:COO) on 3/13/2024 |
MEG MEG Energy | C$30.35 +0.7% | 3/12/2024 | Target Raised by | JPMorgan Chase & Co. | - | | C$33.00 -> C$34.00 | N/A | View details for JPMorgan Chase & Co. rating of MEG Energy (TSE:MEG) on 3/12/2024 |
BARC Barclays | GBX 176.52 -0.2% | 3/12/2024 | Reiterated by | JPMorgan Chase & Co. | - | Overweight | | N/A | View details for JPMorgan Chase & Co. rating of Barclays (LON:BARC) on 3/12/2024 |
DG Dollar General | $155.76 +2.5% | 3/12/2024 | Upgraded by | JPMorgan Chase & Co. | - | Underweight -> Neutral | $120.00 -> $158.00 | Low | View details for JPMorgan Chase & Co. rating of Dollar General (NYSE:DG) on 3/12/2024 |
SAIA Saia | $560.75 -3.0% | 3/11/2024 | Initiated by | JPMorgan Chase & Co. | - | Overweight | $676.00 | Low | View details for JPMorgan Chase & Co. rating of Saia (NASDAQ:SAIA) on 3/11/2024 |
ODFL Old Dominion Freight Line | $418.74 -0.6% | 3/11/2024 | Initiated by | JPMorgan Chase & Co. | - | Neutral | $465.00 | Low | View details for JPMorgan Chase & Co. rating of Old Dominion Freight Line (NASDAQ:ODFL) on 3/11/2024 |
KSPI Joint Stock Company Kaspi.kz | $114.05 +1.2% | 3/11/2024 | Initiated by | JPMorgan Chase & Co. | - | Overweight | $159.00 | Low | View details for JPMorgan Chase & Co. rating of Joint Stock Company Kaspi.kz (NASDAQ:KSPI) on 3/11/2024 |
DUOL Duolingo | $216.53 +0.1% | 3/11/2024 | Initiated by | JPMorgan Chase & Co. | - | Overweight | $270.00 | Low | View details for JPMorgan Chase & Co. rating of Duolingo (NASDAQ:DUOL) on 3/11/2024 |
The AI Bottleneck No One is Talking About (Ad) Renewable energy is growing at an impressive speed - but not fast enough.
This could be one of the greatest periods for the nuclear industry ever. Click here to see who's preparing to meet these needs |
ARCB ArcBest | $125.23 -2.6% | 3/11/2024 | Initiated by | JPMorgan Chase & Co. | - | Overweight | $168.00 | Low | View details for JPMorgan Chase & Co. rating of ArcBest (NASDAQ:ARCB) on 3/11/2024 |
KC Kingsoft Cloud | $3.37 +9.8% | 3/11/2024 | Upgraded by | JPMorgan Chase & Co. | - | Neutral -> Overweight | | Low | View details for JPMorgan Chase & Co. rating of Kingsoft Cloud (NASDAQ:KC) on 3/11/2024 |
BILI Bilibili | $11.84 +0.5% | 3/11/2024 | Upgraded by | JPMorgan Chase & Co. | - | Underweight -> Neutral | $10.00 -> $11.00 | Low | View details for JPMorgan Chase & Co. rating of Bilibili (NASDAQ:BILI) on 3/11/2024 |
VET Vermilion Energy | C$16.06 +5.0% | 3/8/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight | C$23.00 -> C$21.00 | N/A | View details for JPMorgan Chase & Co. rating of Vermilion Energy (TSE:VET) on 3/8/2024 |
TEVA Teva Pharmaceutical Industries | $13.32 -0.9% | 3/8/2024 | Upgraded by | JPMorgan Chase & Co. | - | Underweight -> Neutral | $14.00 | Low | View details for JPMorgan Chase & Co. rating of Teva Pharmaceutical Industries (NYSE:TEVA) on 3/8/2024 |
RWAY Runway Growth Finance | $11.75 -0.6% | 3/8/2024 | Downgraded by | JPMorgan Chase & Co. | - | Overweight -> Neutral | $13.50 -> $12.50 | Low | View details for JPMorgan Chase & Co. rating of Runway Growth Finance (NASDAQ:RWAY) on 3/8/2024 |
KGS Kodiak Gas Services | $26.13 -0.2% | 3/8/2024 | Downgraded by | JPMorgan Chase & Co. | - | Overweight -> Neutral | $27.00 | Low | View details for JPMorgan Chase & Co. rating of Kodiak Gas Services (NYSE:KGS) on 3/8/2024 |
HESM Hess Midstream | $35.31 +0.3% | 3/8/2024 | Downgraded by | JPMorgan Chase & Co. | - | Overweight -> Neutral | $37.00 | Low | View details for JPMorgan Chase & Co. rating of Hess Midstream (NYSE:HESM) on 3/8/2024 |
KNTK Kinetik | $36.99 +0.9% | 3/8/2024 | Upgraded by | JPMorgan Chase & Co. | - | Neutral -> Overweight | $38.00 -> $40.00 | Low | View details for JPMorgan Chase & Co. rating of Kinetik (NASDAQ:KNTK) on 3/8/2024 |
GE General Electric | $169.91 +0.6% | 3/8/2024 | Upgraded by | JPMorgan Chase & Co. | - | Neutral -> Overweight | $166.00 -> $180.00 | Low | View details for JPMorgan Chase & Co. rating of General Electric (NYSE:GE) on 3/8/2024 |
SSE SSE | GBX 1,609 +1.6% | 3/7/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Top Pick | GBX 2,125 -> GBX 2,050 | N/A | View details for JPMorgan Chase & Co. rating of SSE (LON:SSE) on 3/7/2024 |
LRE Lancashire | GBX 640.50 +4.1% | 3/7/2024 | Reiterated by | JPMorgan Chase & Co. | - | Neutral | GBX 750 | N/A | View details for JPMorgan Chase & Co. rating of Lancashire (LON:LRE) on 3/7/2024 |
CTEC ConvaTec Group | GBX 288 -0.1% | 3/7/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight | GBX 300 -> GBX 323 | N/A | View details for JPMorgan Chase & Co. rating of ConvaTec Group (LON:CTEC) on 3/7/2024 |
PCRX Pacira BioSciences | $29.29 -0.4% | 3/7/2024 | Initiated by | JPMorgan Chase & Co. | - | Overweight | $80.00 -> $45.00 | Low | View details for JPMorgan Chase & Co. rating of Pacira BioSciences (NASDAQ:PCRX) on 3/7/2024 |
VSCO Victoria's Secret & Co. | $18.19 -0.8% | 3/7/2024 | Reiterated by | JPMorgan Chase & Co. | - | Neutral -> Underweight | $22.00 -> $15.00 | Low | View details for JPMorgan Chase & Co. rating of Victoria’s Secret & Co. (NYSE:VSCO) on 3/7/2024 |
FM First Quantum Minerals | C$14.69 -2.1% | 3/6/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral | C$11.00 -> C$12.00 | N/A | View details for JPMorgan Chase & Co. rating of First Quantum Minerals (TSE:FM) on 3/6/2024 |
HSIC Henry Schein | $74.18 -0.5% | 3/6/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $82.00 -> $88.00 | Low | View details for JPMorgan Chase & Co. rating of Henry Schein (NASDAQ:HSIC) on 3/6/2024 |
NUVL Nuvalent | $78.11 -3.3% | 3/6/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $68.00 -> $98.00 | Low | View details for JPMorgan Chase & Co. rating of Nuvalent (NASDAQ:NUVL) on 3/6/2024 |
PAY Paymentus | $22.37 -3.4% | 3/6/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $17.00 -> $19.00 | N/A | View details for JPMorgan Chase & Co. rating of Paymentus (NYSE:PAY) on 3/6/2024 |
AKYA Akoya Biosciences | $4.94 +0.6% | 3/6/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $12.00 -> $10.00 | Low | View details for JPMorgan Chase & Co. rating of Akoya Biosciences (NASDAQ:AKYA) on 3/6/2024 |
CCOI Cogent Communications | $63.60 -2.0% | 3/6/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $74.00 -> $73.00 | Low | View details for JPMorgan Chase & Co. rating of Cogent Communications (NASDAQ:CCOI) on 3/6/2024 |
HR Healthcare Realty Trust | $13.13 -0.3% | 3/6/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $19.00 -> $17.00 | Low | View details for JPMorgan Chase & Co. rating of Healthcare Realty Trust (NYSE:HR) on 3/6/2024 |
PDCO Patterson Companies | $26.78 -1.6% | 3/6/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $31.00 -> $30.00 | Low | View details for JPMorgan Chase & Co. rating of Patterson Companies (NASDAQ:PDCO) on 3/6/2024 |
PRVA Privia Health Group | $20.14 -1.0% | 3/6/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $38.00 -> $30.00 | Low | View details for JPMorgan Chase & Co. rating of Privia Health Group (NASDAQ:PRVA) on 3/6/2024 |
APLS Apellis Pharmaceuticals | $56.26 -0.8% | 3/6/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $78.00 -> $79.00 | Low | View details for JPMorgan Chase & Co. rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 3/6/2024 |
APG APi Group | $37.78 -0.7% | 3/6/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $31.00 -> $35.00 | Low | View details for JPMorgan Chase & Co. rating of APi Group (NYSE:APG) on 3/6/2024 |
CRWD CrowdStrike | $321.06 +1.7% | 3/6/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $350.00 -> $371.00 | N/A | View details for JPMorgan Chase & Co. rating of CrowdStrike (NASDAQ:CRWD) on 3/6/2024 |
SG Sweetgreen | $22.08 -0.5% | 3/6/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $13.00 -> $20.00 | Low | View details for JPMorgan Chase & Co. rating of Sweetgreen (NYSE:SG) on 3/6/2024 |
SWTX SpringWorks Therapeutics | $48.43 -3.7% | 3/6/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $73.00 -> $74.00 | Low | View details for JPMorgan Chase & Co. rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 3/6/2024 |
TRGP Targa Resources | $107.36 +1.3% | 3/6/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $122.00 -> $125.00 | Low | View details for JPMorgan Chase & Co. rating of Targa Resources (NYSE:TRGP) on 3/6/2024 |
ROST Ross Stores | $144.31 -0.6% | 3/6/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $150.00 -> $163.00 | Low | View details for JPMorgan Chase & Co. rating of Ross Stores (NASDAQ:ROST) on 3/6/2024 |
JWN Nordstrom | $17.05 -1.4% | 3/6/2024 | Target Raised by | JPMorgan Chase & Co. | - | Underweight -> Underweight | $14.00 -> $15.00 | Low | View details for JPMorgan Chase & Co. rating of Nordstrom (NYSE:JWN) on 3/6/2024 |
NIO NIO | $5.55 -0.7% | 3/6/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Underweight -> Underweight | $5.00 -> $4.80 | Low | View details for JPMorgan Chase & Co. rating of NIO (NYSE:NIO) on 3/6/2024 |
BOX BOX | $29.13 -0.9% | 3/6/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $31.00 -> $32.00 | Low | View details for JPMorgan Chase & Co. rating of BOX (NYSE:BOX) on 3/6/2024 |
TBBB BBB Foods | $21.92 +1.0% | 3/6/2024 | Initiated by | JPMorgan Chase & Co. | - | Overweight | $30.00 | N/A | View details for JPMorgan Chase & Co. rating of BBB Foods (NYSE:TBBB) on 3/6/2024 |
ICAGY International Consolidated Airlines Group | $3.93 -1.5% | 3/6/2024 | Upgraded by | JPMorgan Chase & Co. | - | Underweight -> Overweight | | N/A | View details for JPMorgan Chase & Co. rating of International Consolidated Airlines Group (OTCMKTS:ICAGY) on 3/6/2024 |
PSON Pearson | GBX 1,017.50 -0.1% | 3/5/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight | GBX 1,160 -> GBX 1,200 | N/A | View details for JPMorgan Chase & Co. rating of Pearson (LON:PSON) on 3/5/2024 |
SDR Schroders | GBX 382.10 -2.1% | 3/5/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight | GBX 490 -> GBX 489 | N/A | View details for JPMorgan Chase & Co. rating of Schroders (LON:SDR) on 3/5/2024 |
CKN Clarkson | GBX 3,875 -1.4% | 3/5/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight | GBX 4,080 -> GBX 4,320 | N/A | View details for JPMorgan Chase & Co. rating of Clarkson (LON:CKN) on 3/5/2024 |
HWDN Howden Joinery Group | GBX 858.80 -0.9% | 3/5/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral | GBX 670 -> GBX 680 | N/A | View details for JPMorgan Chase & Co. rating of Howden Joinery Group (LON:HWDN) on 3/5/2024 |
TRST Trustpilot Group | GBX 205.20 +2.1% | 3/5/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight | GBX 190 -> GBX 250 | N/A | View details for JPMorgan Chase & Co. rating of Trustpilot Group (LON:TRST) on 3/5/2024 |
PCAR PACCAR | $120.34 +1.7% | 3/5/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $116.00 -> $135.00 | Low | View details for JPMorgan Chase & Co. rating of PACCAR (NASDAQ:PCAR) on 3/5/2024 |
DDL Dingdong (Cayman) | $1.28 -2.3% | 3/5/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Underweight -> Underweight | $1.40 -> $1.15 | Low | View details for JPMorgan Chase & Co. rating of Dingdong (Cayman) (NYSE:DDL) on 3/5/2024 |
CIEN Ciena | $49.50 -1.0% | 3/5/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $56.00 -> $67.00 | Low | View details for JPMorgan Chase & Co. rating of Ciena (NYSE:CIEN) on 3/5/2024 |
MGX Metagenomi | $11.07 +9.2% | 3/5/2024 | Initiated by | JPMorgan Chase & Co. | - | Overweight | $16.00 | Low | View details for JPMorgan Chase & Co. rating of Metagenomi (NASDAQ:MGX) on 3/5/2024 |
AMPH Amphastar Pharmaceuticals | $42.85 -0.5% | 3/5/2024 | Initiated by | JPMorgan Chase & Co. | - | Overweight | $60.00 | Low | View details for JPMorgan Chase & Co. rating of Amphastar Pharmaceuticals (NASDAQ:AMPH) on 3/5/2024 |
SE SEA | $57.85 -0.5% | 3/5/2024 | Upgraded by | JPMorgan Chase & Co. | - | Neutral -> Overweight | $43.00 -> $70.00 | Low | View details for JPMorgan Chase & Co. rating of SEA (NYSE:SE) on 3/5/2024 |
CNQ Canadian Natural Resources | C$99.36 +1.1% | 3/4/2024 | Target Raised by | JPMorgan Chase & Co. | - | | C$102.00 -> C$106.00 | N/A | View details for JPMorgan Chase & Co. rating of Canadian Natural Resources (TSE:CNQ) on 3/4/2024 |
SHAK Shake Shack | $104.79 +1.1% | 3/4/2024 | Target Raised by | JPMorgan Chase & Co. | - | Underweight -> Underweight | $65.00 -> $100.00 | Low | View details for JPMorgan Chase & Co. rating of Shake Shack (NYSE:SHAK) on 3/4/2024 |
GE General Electric | $169.91 +0.6% | 3/4/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $134.00 -> $166.00 | Low | View details for JPMorgan Chase & Co. rating of General Electric (NYSE:GE) on 3/4/2024 |
My next big prediction isn’t a prediction (Ad) I believe this could change your life forever.
I’m talking about transforming everything for you, financially.
You see, a rare market anomaly has emerged that I believe is going to make some people very wealthy.
Almost nobody in the mainstream media or Wall Street has connected the dots on what’s going on, but that ignorance won’t last for long. When they wake up to this situation, billions of dollars will flood in. Click here now to sign up |
COMM CommScope | $1.41 -6.6% | 3/4/2024 | Reiterated by | JPMorgan Chase & Co. | - | Neutral -> Underweight | | Low | View details for JPMorgan Chase & Co. rating of CommScope (NASDAQ:COMM) on 3/4/2024 |
KYTX Kyverna Therapeutics | $26.75 -10.0% | 3/4/2024 | Initiated by | JPMorgan Chase & Co. | - | Overweight | $39.00 | Low | View details for JPMorgan Chase & Co. rating of Kyverna Therapeutics (NASDAQ:KYTX) on 3/4/2024 |
MCB Metropolitan Bank | $36.93 -1.2% | 3/4/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $62.00 -> $55.00 | Low | View details for JPMorgan Chase & Co. rating of Metropolitan Bank (NYSE:MCB) on 3/4/2024 |
STJ St. James's Place | GBX 415.30 -2.4% | 3/1/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral | GBX 793 -> GBX 637 | N/A | View details for JPMorgan Chase & Co. rating of St. James’s Place (LON:STJ) on 3/1/2024 |
PHP Primary Health Properties | GBX 91.15 +0.3% | 3/1/2024 | Initiated by | JPMorgan Chase & Co. | - | Neutral | GBX 105 | N/A | View details for JPMorgan Chase & Co. rating of Primary Health Properties (LON:PHP) on 3/1/2024 |
STER Sterling Check | $15.88 -0.3% | 3/1/2024 | Reiterated by | JPMorgan Chase & Co. | - | Overweight -> Neutral | $17.00 | Low | View details for JPMorgan Chase & Co. rating of Sterling Check (NASDAQ:STER) on 3/1/2024 |
FIHL Fidelis Insurance | $18.99 +1.8% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $15.00 -> $16.00 | Low | View details for JPMorgan Chase & Co. rating of Fidelis Insurance (NYSE:FIHL) on 3/1/2024 |
HRL Hormel Foods | $34.35 +0.6% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Underweight -> Underweight | $27.00 -> $28.00 | Low | View details for JPMorgan Chase & Co. rating of Hormel Foods (NYSE:HRL) on 3/1/2024 |
NTAP NetApp | $101.80 -0.5% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Underweight -> Underweight | $87.00 -> $95.00 | Low | View details for JPMorgan Chase & Co. rating of NetApp (NASDAQ:NTAP) on 3/1/2024 |
SE SEA | $57.85 -0.5% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $40.00 -> $43.00 | Low | View details for JPMorgan Chase & Co. rating of SEA (NYSE:SE) on 3/1/2024 |
TGT Target | $167.61 +2.1% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $125.00 -> $157.00 | Low | View details for JPMorgan Chase & Co. rating of Target (NYSE:TGT) on 3/1/2024 |
COO Cooper Companies | $100.82 +0.1% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $94.00 -> $100.00 | Low | View details for JPMorgan Chase & Co. rating of Cooper Companies (NASDAQ:COO) on 3/1/2024 |
TREX Trex | $94.72 +0.3% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $79.00 -> $93.00 | Low | View details for JPMorgan Chase & Co. rating of Trex (NYSE:TREX) on 3/1/2024 |
VTEX VTEX | $8.80 +1.4% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $6.50 -> $9.00 | Low | View details for JPMorgan Chase & Co. rating of VTEX (NYSE:VTEX) on 3/1/2024 |
FRO Frontline | $23.69 +0.2% | 3/1/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $23.00 -> $22.30 | Low | View details for JPMorgan Chase & Co. rating of Frontline (NYSE:FRO) on 3/1/2024 |
TGNA TEGNA | $14.33 -3.4% | 3/1/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $17.00 -> $15.00 | Low | View details for JPMorgan Chase & Co. rating of TEGNA (NYSE:TGNA) on 3/1/2024 |
WHF WhiteHorse Finance | $12.74 +0.4% | 3/1/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Underweight -> Underweight | $12.00 -> $11.50 | Low | View details for JPMorgan Chase & Co. rating of WhiteHorse Finance (NASDAQ:WHF) on 3/1/2024 |
BBY Best Buy | $77.13 -1.1% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $78.00 -> $89.00 | Low | View details for JPMorgan Chase & Co. rating of Best Buy (NYSE:BBY) on 3/1/2024 |
BJ BJ's Wholesale Club | $76.40 +1.7% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Underweight -> Underweight | $58.00 -> $62.00 | Low | View details for JPMorgan Chase & Co. rating of BJ’s Wholesale Club (NYSE:BJ) on 3/1/2024 |
ESAB ESAB | $102.29 +2.9% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $84.00 -> $111.00 | Low | View details for JPMorgan Chase & Co. rating of ESAB (NYSE:ESAB) on 3/1/2024 |
CPB Campbell Soup | $43.32 +1.4% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $47.00 -> $48.00 | Low | View details for JPMorgan Chase & Co. rating of Campbell Soup (NYSE:CPB) on 3/1/2024 |
DAVA Endava | $37.21 +1.7% | 3/1/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $79.00 -> $49.00 | Low | View details for JPMorgan Chase & Co. rating of Endava (NYSE:DAVA) on 3/1/2024 |
ACAD ACADIA Pharmaceuticals | $18.72 +1.3% | 3/1/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $32.00 -> $29.00 | Low | View details for JPMorgan Chase & Co. rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 3/1/2024 |
MEG Montrose Environmental Group | $36.47 -3.0% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $41.00 -> $47.00 | N/A | View details for JPMorgan Chase & Co. rating of Montrose Environmental Group (NYSE:MEG) on 3/1/2024 |
H Hyatt Hotels | $156.09 +1.6% | 3/1/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $162.00 -> $172.00 | N/A | View details for JPMorgan Chase & Co. rating of Hyatt Hotels (NYSE:H) on 3/1/2024 |
GDRX GoodRx | $6.57 -4.9% | 3/1/2024 | Upgraded by | JPMorgan Chase & Co. | - | Neutral -> Overweight | $7.00 -> $10.00 | Low | View details for JPMorgan Chase & Co. rating of GoodRx (NASDAQ:GDRX) on 3/1/2024 |
ABEV Ambev | $2.51
| 3/1/2024 | Reiterated by | JPMorgan Chase & Co. | - | Overweight -> Neutral | | Low | View details for JPMorgan Chase & Co. rating of Ambev (NYSE:ABEV) on 3/1/2024 |
ANNX Annexon | $6.29 -6.0% | 3/1/2024 | Upgraded by | JPMorgan Chase & Co. | - | Neutral -> Overweight | $11.00 | Low | View details for JPMorgan Chase & Co. rating of Annexon (NASDAQ:ANNX) on 3/1/2024 |
NXT Nextracker | $59.16 -0.6% | 2/29/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $73.00 -> $67.00 | Low | View details for JPMorgan Chase & Co. rating of Nextracker (NASDAQ:NXT) on 2/29/2024 |
SHLS Shoals Technologies Group | $11.71 -2.9% | 2/29/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $32.00 -> $26.00 | Low | View details for JPMorgan Chase & Co. rating of Shoals Technologies Group (NASDAQ:SHLS) on 2/29/2024 |
SLRC SLR Investment | $15.03 -0.7% | 2/29/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $15.50 -> $15.00 | Low | View details for JPMorgan Chase & Co. rating of SLR Investment (NASDAQ:SLRC) on 2/29/2024 |
SNOW Snowflake | $156.31 -0.4% | 2/29/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $200.00 -> $170.00 | Low | View details for JPMorgan Chase & Co. rating of Snowflake (NYSE:SNOW) on 2/29/2024 |
AAP Advance Auto Parts | $84.21 +3.0% | 2/29/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $55.00 -> $68.00 | Low | View details for JPMorgan Chase & Co. rating of Advance Auto Parts (NYSE:AAP) on 2/29/2024 |
ALKT Alkami Technology | $23.09 -0.1% | 2/29/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $27.00 -> $31.00 | Low | View details for JPMorgan Chase & Co. rating of Alkami Technology (NASDAQ:ALKT) on 2/29/2024 |
AVDX AvidXchange | $12.75 +2.7% | 2/29/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $14.00 -> $15.00 | Low | View details for JPMorgan Chase & Co. rating of AvidXchange (NASDAQ:AVDX) on 2/29/2024 |
CAVA CAVA Group | $62.07 -3.3% | 2/29/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $40.00 -> $50.00 | Low | View details for JPMorgan Chase & Co. rating of CAVA Group (NYSE:CAVA) on 2/29/2024 |
BAP Credicorp | $172.90 +0.2% | 2/29/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $190.00 -> $194.00 | Low | View details for JPMorgan Chase & Co. rating of Credicorp (NYSE:BAP) on 2/29/2024 |
CRWD CrowdStrike | $321.06 +1.7% | 2/29/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $300.00 -> $350.00 | Low | View details for JPMorgan Chase & Co. rating of CrowdStrike (NASDAQ:CRWD) on 2/29/2024 |
ESTA Establishment Labs | $50.69 +3.5% | 2/29/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $46.00 -> $53.00 | Low | View details for JPMorgan Chase & Co. rating of Establishment Labs (NASDAQ:ESTA) on 2/29/2024 |
PSTG Pure Storage | $50.60 +1.3% | 2/29/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $45.00 -> $50.00 | Low | View details for JPMorgan Chase & Co. rating of Pure Storage (NYSE:PSTG) on 2/29/2024 |
RXST RxSight | $46.76 -0.9% | 2/29/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $40.00 -> $62.00 | Low | View details for JPMorgan Chase & Co. rating of RxSight (NASDAQ:RXST) on 2/29/2024 |
CRM Salesforce | $300.51 +2.1% | 2/29/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $260.00 -> $310.00 | Low | View details for JPMorgan Chase & Co. rating of Salesforce (NYSE:CRM) on 2/29/2024 |
SILK Silk Road Medical | $16.99 +7.2% | 2/29/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $10.00 -> $19.00 | Low | View details for JPMorgan Chase & Co. rating of Silk Road Medical (NASDAQ:SILK) on 2/29/2024 |
PRKS United Parks & Resorts | $52.90 +3.0% | 2/29/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $57.00 -> $61.00 | Low | View details for JPMorgan Chase & Co. rating of United Parks & Resorts (NYSE:PRKS) on 2/29/2024 |
VCSA Vacasa | $6.47 +2.4% | 2/29/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $8.00 -> $10.00 | Low | View details for JPMorgan Chase & Co. rating of Vacasa (NASDAQ:VCSA) on 2/29/2024 |
DV DoubleVerify | $33.92 +2.5% | 2/29/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $32.00 -> $30.00 | Low | View details for JPMorgan Chase & Co. rating of DoubleVerify (NYSE:DV) on 2/29/2024 |
ENLC EnLink Midstream | $12.93 -0.2% | 2/29/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $15.00 -> $14.00 | Low | View details for JPMorgan Chase & Co. rating of EnLink Midstream (NYSE:ENLC) on 2/29/2024 |
JAZZ Jazz Pharmaceuticals | $123.41 +2.1% | 2/29/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $180.00 -> $170.00 | Low | View details for JPMorgan Chase & Co. rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 2/29/2024 |
GOGO Gogo | $8.28 -5.8% | 2/29/2024 | Initiated by | JPMorgan Chase & Co. | - | Neutral | $15.00 -> $11.00 | Low | View details for JPMorgan Chase & Co. rating of Gogo (NASDAQ:GOGO) on 2/29/2024 |
CWAN Clearwater Analytics | $16.82 +1.3% | 2/29/2024 | Downgraded by | JPMorgan Chase & Co. | - | Overweight -> Neutral | $24.00 -> $22.00 | Low | View details for JPMorgan Chase & Co. rating of Clearwater Analytics (NYSE:CWAN) on 2/29/2024 |
BlackRock Bets Big on Tiny Biotech (Ad) An undervalued biotech firm is on the verge of a major discovery -
That has the potential to treat Alzheimer's, Parkinson's and Dementia.
BlackRock is so confident in this firm, they've invested $298 million. Click here for the full story >>> |
AZO AutoZone | $3,106.87 -0.6% | 2/28/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $3,000.00 -> $3,200.00 | Low | View details for JPMorgan Chase & Co. rating of AutoZone (NYSE:AZO) on 2/28/2024 |
AXON Axon Enterprise | $308.45 +0.3% | 2/28/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $285.00 -> $330.00 | Low | View details for JPMorgan Chase & Co. rating of Axon Enterprise (NASDAQ:AXON) on 2/28/2024 |
FLYW Flywire | $25.78 +0.7% | 2/28/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $29.00 -> $32.00 | Low | View details for JPMorgan Chase & Co. rating of Flywire (NASDAQ:FLYW) on 2/28/2024 |
SJM J. M. Smucker | $122.68 +0.5% | 2/28/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $126.00 -> $128.00 | Low | View details for JPMorgan Chase & Co. rating of J. M. Smucker (NYSE:SJM) on 2/28/2024 |
TREE LendingTree | $36.46 -3.9% | 2/28/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $25.00 -> $38.00 | Low | View details for JPMorgan Chase & Co. rating of LendingTree (NASDAQ:TREE) on 2/28/2024 |
LNW Light & Wonder | $99.42 -0.4% | 2/28/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $98.00 -> $107.00 | Low | View details for JPMorgan Chase & Co. rating of Light & Wonder (NASDAQ:LNW) on 2/28/2024 |
LOW Lowe's Companies | $243.48 -0.5% | 2/28/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $265.00 -> $268.00 | Low | View details for JPMorgan Chase & Co. rating of Lowe’s Companies (NYSE:LOW) on 2/28/2024 |
MFIC MidCap Financial Investment | $14.35 -0.1% | 2/28/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $14.00 -> $14.50 | Low | View details for JPMorgan Chase & Co. rating of MidCap Financial Investment (NASDAQ:MFIC) on 2/28/2024 |
PRFT Perficient | $60.19 -0.1% | 2/28/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $68.00 -> $71.00 | Low | View details for JPMorgan Chase & Co. rating of Perficient (NASDAQ:PRFT) on 2/28/2024 |
PTGX Protagonist Therapeutics | $28.46 -1.8% | 2/28/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $34.00 -> $37.00 | Low | View details for JPMorgan Chase & Co. rating of Protagonist Therapeutics (NASDAQ:PTGX) on 2/28/2024 |
RYAN Ryan Specialty | $55.33 -0.3% | 2/28/2024 | Target Raised by | JPMorgan Chase & Co. | - | Underweight -> Underweight | $44.00 -> $47.00 | Low | View details for JPMorgan Chase & Co. rating of Ryan Specialty (NYSE:RYAN) on 2/28/2024 |
ADNT Adient | $32.53 -0.2% | 2/28/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $41.00 -> $40.00 | Low | View details for JPMorgan Chase & Co. rating of Adient (NYSE:ADNT) on 2/28/2024 |
AMT American Tower | $195.91 -0.7% | 2/28/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $236.00 -> $230.00 | Low | View details for JPMorgan Chase & Co. rating of American Tower (NYSE:AMT) on 2/28/2024 |
ARRY Array Technologies | $11.94 +1.8% | 2/28/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $35.00 -> $29.00 | N/A | View details for JPMorgan Chase & Co. rating of Array Technologies (NASDAQ:ARRY) on 2/28/2024 |
BMBL Bumble | $10.82 +0.7% | 2/28/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $20.00 -> $17.00 | Low | View details for JPMorgan Chase & Co. rating of Bumble (NASDAQ:BMBL) on 2/28/2024 |
FSK FS KKR Capital | $18.42 -0.4% | 2/28/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $20.00 -> $18.00 | Low | View details for JPMorgan Chase & Co. rating of FS KKR Capital (NYSE:FSK) on 2/28/2024 |
PRGO Perrigo | $30.01 -1.2% | 2/28/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $48.00 -> $41.00 | Low | View details for JPMorgan Chase & Co. rating of Perrigo (NYSE:PRGO) on 2/28/2024 |
URBN Urban Outfitters | $42.80 -0.3% | 2/28/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $46.00 -> $44.00 | Low | View details for JPMorgan Chase & Co. rating of Urban Outfitters (NASDAQ:URBN) on 2/28/2024 |
APO Apollo Global Management | $110.27 -0.1% | 2/28/2024 | Initiated by | JPMorgan Chase & Co. | - | Neutral -> Overweight | $122.00 | Low | View details for JPMorgan Chase & Co. rating of Apollo Global Management (NYSE:APO) on 2/28/2024 |
IBP Installed Building Products | $240.16 +0.4% | 2/28/2024 | Downgraded by | JPMorgan Chase & Co. | - | Overweight -> Neutral | $199.00 -> $242.00 | Low | View details for JPMorgan Chase & Co. rating of Installed Building Products (NYSE:IBP) on 2/28/2024 |
MELI MercadoLibre | $1,509.05 +0.6% | 2/27/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $2,000.00 -> $2,150.00 | Low | View details for JPMorgan Chase & Co. rating of MercadoLibre (NASDAQ:MELI) on 2/27/2024 |
TMDX TransMedics Group | $74.16 -2.3% | 2/27/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $87.00 -> $105.00 | Low | View details for JPMorgan Chase & Co. rating of TransMedics Group (NASDAQ:TMDX) on 2/27/2024 |
RARE Ultragenyx Pharmaceutical | $46.59 -1.6% | 2/27/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $84.00 -> $88.00 | Low | View details for JPMorgan Chase & Co. rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 2/27/2024 |
WYNN Wynn Resorts | $98.84 -0.3% | 2/27/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $118.00 -> $123.00 | Low | View details for JPMorgan Chase & Co. rating of Wynn Resorts (NASDAQ:WYNN) on 2/27/2024 |
ALLO Allogene Therapeutics | $4.20 -9.9% | 2/27/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $9.00 -> $8.00 | Low | View details for JPMorgan Chase & Co. rating of Allogene Therapeutics (NASDAQ:ALLO) on 2/27/2024 |
OPAD Offerpad Solutions | $7.84 -3.2% | 2/27/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $10.00 -> $9.00 | Low | View details for JPMorgan Chase & Co. rating of Offerpad Solutions (NYSE:OPAD) on 2/27/2024 |
RCKT Rocket Pharmaceuticals | $26.52 -1.1% | 2/27/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $55.00 -> $50.00 | Low | View details for JPMorgan Chase & Co. rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 2/27/2024 |
ZM Zoom Video Communications | $66.23 +0.4% | 2/27/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $83.00 -> $80.00 | Low | View details for JPMorgan Chase & Co. rating of Zoom Video Communications (NASDAQ:ZM) on 2/27/2024 |
COGT Cogent Biosciences | $6.74 -4.4% | 2/27/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $18.00 -> $20.00 | Low | View details for JPMorgan Chase & Co. rating of Cogent Biosciences (NASDAQ:COGT) on 2/27/2024 |
EDIT Editas Medicine | $7.72 -5.0% | 2/27/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $8.00 -> $9.00 | Low | View details for JPMorgan Chase & Co. rating of Editas Medicine (NASDAQ:EDIT) on 2/27/2024 |
EVER EverQuote | $17.17 -2.2% | 2/27/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $13.00 -> $25.00 | Low | View details for JPMorgan Chase & Co. rating of EverQuote (NASDAQ:EVER) on 2/27/2024 |
FRPT Freshpet | $108.41 -1.0% | 2/27/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $67.00 -> $102.00 | Low | View details for JPMorgan Chase & Co. rating of Freshpet (NASDAQ:FRPT) on 2/27/2024 |
CPRT Copart | $56.09 -0.1% | 2/27/2024 | Initiated by | JPMorgan Chase & Co. | - | Neutral | $48.00 | Low | View details for JPMorgan Chase & Co. rating of Copart (NASDAQ:CPRT) on 2/27/2024 |
DPZ Domino's Pizza | $442.86 +0.4% | 2/27/2024 | Reiterated by | JPMorgan Chase & Co. | - | Overweight -> Neutral | $420.00 -> $430.00 | Low | View details for JPMorgan Chase & Co. rating of Domino’s Pizza (NYSE:DPZ) on 2/27/2024 |
EZJ easyJet | GBX 534 +0.8% | 2/27/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight | GBX 690 -> GBX 680 | N/A | View details for JPMorgan Chase & Co. rating of easyJet (LON:EZJ) on 2/27/2024 |
IHG InterContinental Hotels Group | GBX 8,028 -0.4% | 2/27/2024 | Target Raised by | JPMorgan Chase & Co. | - | Underweight | GBX 5,400 -> GBX 6,100 | N/A | View details for JPMorgan Chase & Co. rating of InterContinental Hotels Group (LON:IHG) on 2/27/2024 |
WIZZ Wizz Air | GBX 2,073 -3.4% | 2/27/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral | GBX 2,150 -> GBX 2,250 | N/A | View details for JPMorgan Chase & Co. rating of Wizz Air (LON:WIZZ) on 2/27/2024 |
DGE Diageo | GBX 2,868.50 -1.3% | 2/26/2024 | Reiterated by | JPMorgan Chase & Co. | - | Neutral | | N/A | View details for JPMorgan Chase & Co. rating of Diageo (LON:DGE) on 2/26/2024 |
CPG Compass Group | GBX 2,171 -1.4% | 2/26/2024 | Reiterated by | JPMorgan Chase & Co. | - | Overweight | GBX 2,600 | N/A | View details for JPMorgan Chase & Co. rating of Compass Group (LON:CPG) on 2/26/2024 |
LLOY Lloyds Banking Group | GBX 49.39 -0.4% | 2/26/2024 | Reiterated by | JPMorgan Chase & Co. | - | Underweight | GBX 41 | N/A | View details for JPMorgan Chase & Co. rating of Lloyds Banking Group (LON:LLOY) on 2/26/2024 |
RR Rolls-Royce Holdings plc | GBX 393.50 +1.1% | 2/26/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight | GBX 400 -> GBX 475 | N/A | View details for JPMorgan Chase & Co. rating of Rolls-Royce Holdings plc (LON:RR) on 2/26/2024 |
STAN Standard Chartered | GBX 650.20 -0.6% | 2/26/2024 | Reiterated by | JPMorgan Chase & Co. | - | Overweight | GBX 850 | N/A | View details for JPMorgan Chase & Co. rating of Standard Chartered (LON:STAN) on 2/26/2024 |
SPI Spire Healthcare Group | GBX 234.50 -0.2% | 2/26/2024 | Reiterated by | JPMorgan Chase & Co. | - | Overweight | GBX 295 | N/A | View details for JPMorgan Chase & Co. rating of Spire Healthcare Group (LON:SPI) on 2/26/2024 |
GPS GAP | $24.69 +4.7% | 2/26/2024 | Upgraded by | JPMorgan Chase & Co. | - | Underweight -> Neutral | $16.00 -> $20.00 | Low | View details for JPMorgan Chase & Co. rating of GAP (NYSE:GPS) on 2/26/2024 |
WBD Warner Bros. Discovery | $8.48 -0.7% | 2/26/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $13.00 -> $10.00 | Low | View details for JPMorgan Chase & Co. rating of Warner Bros. Discovery (NASDAQ:WBD) on 2/26/2024 |
KNSL Kinsale Capital Group | $515.81 -0.1% | 2/26/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $375.00 -> $420.00 | Low | View details for JPMorgan Chase & Co. rating of Kinsale Capital Group (NYSE:KNSL) on 2/26/2024 |
TXRH Texas Roadhouse | $152.00 -0.2% | 2/26/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $120.00 -> $142.00 | Low | View details for JPMorgan Chase & Co. rating of Texas Roadhouse (NASDAQ:TXRH) on 2/26/2024 |
PLNT Planet Fitness | $59.70 -1.5% | 2/26/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $75.00 -> $72.00 | Low | View details for JPMorgan Chase & Co. rating of Planet Fitness (NYSE:PLNT) on 2/26/2024 |
LAMR Lamar Advertising | $116.18 +0.1% | 2/26/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $92.00 -> $109.00 | Low | View details for JPMorgan Chase & Co. rating of Lamar Advertising (NASDAQ:LAMR) on 2/26/2024 |
ZS Zscaler | $195.94 +1.0% | 2/26/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $212.00 -> $240.00 | Low | View details for JPMorgan Chase & Co. rating of Zscaler (NASDAQ:ZS) on 2/26/2024 |
Central Bank Gold Heist In Progress (Ad) When central banks buy gold…
The rich buy right along with them.
And central banks are buying at breakneck pace.
Last year… 1,037 tons.
Just 45 tons less than the record set two years ago. That's why we have released our Free Precious Metals Investment Guide. |
OKTA Okta | $105.88 -0.2% | 2/26/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $74.00 -> $88.00 | Low | View details for JPMorgan Chase & Co. rating of Okta (NASDAQ:OKTA) on 2/26/2024 |
DAN Dana | $11.72 +0.9% | 2/26/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $19.00 -> $18.00 | Low | View details for JPMorgan Chase & Co. rating of Dana (NYSE:DAN) on 2/26/2024 |
NTNX Nutanix | $64.78 +2.6% | 2/26/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $54.00 -> $65.00 | Low | View details for JPMorgan Chase & Co. rating of Nutanix (NASDAQ:NTNX) on 2/26/2024 |
DRS Leonardo DRS | $21.55 -1.9% | 2/26/2024 | Initiated by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $23.00 | Low | View details for JPMorgan Chase & Co. rating of Leonardo DRS (NASDAQ:DRS) on 2/26/2024 |
AS Amer Sports | $15.06 -0.5% | 2/26/2024 | Initiated by | JPMorgan Chase & Co. | - | Overweight | $19.00 | Low | View details for JPMorgan Chase & Co. rating of Amer Sports (NYSE:AS) on 2/26/2024 |
TRP TC Energy | C$54.52 +0.1% | 2/23/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral | C$57.00 -> C$60.00 | N/A | View details for JPMorgan Chase & Co. rating of TC Energy (TSE:TRP) on 2/23/2024 |
STLC Stelco | C$41.17 +0.1% | 2/23/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight | C$56.00 -> C$50.00 | N/A | View details for JPMorgan Chase & Co. rating of Stelco (TSE:STLC) on 2/23/2024 |
BKNG Booking | $3,450.93 +1.1% | 2/23/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $3,560.00 -> $3,950.00 | Low | View details for JPMorgan Chase & Co. rating of Booking (NASDAQ:BKNG) on 2/23/2024 |
ENV Envestnet | $54.47 +1.7% | 2/23/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $44.00 -> $45.00 | Low | View details for JPMorgan Chase & Co. rating of Envestnet (NYSE:ENV) on 2/23/2024 |
FIS Fidelity National Information Services | $69.31 +0.3% | 2/23/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $68.00 -> $71.00 | Low | View details for JPMorgan Chase & Co. rating of Fidelity National Information Services (NYSE:FIS) on 2/23/2024 |
THRM Gentherm | $54.24 0.0% | 2/23/2024 | Target Raised by | JPMorgan Chase & Co. | - | Underweight -> Underweight | $58.00 -> $63.00 | Low | View details for JPMorgan Chase & Co. rating of Gentherm (NASDAQ:THRM) on 2/23/2024 |
GDYN Grid Dynamics | $12.69 +1.0% | 2/23/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $16.00 -> $17.00 | Low | View details for JPMorgan Chase & Co. rating of Grid Dynamics (NASDAQ:GDYN) on 2/23/2024 |
IDYA IDEAYA Biosciences | $43.46 -1.9% | 2/23/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $51.00 -> $57.00 | Low | View details for JPMorgan Chase & Co. rating of IDEAYA Biosciences (NASDAQ:IDYA) on 2/23/2024 |
PODD Insulet | $171.68 +3.5% | 2/23/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $190.00 -> $225.00 | Low | View details for JPMorgan Chase & Co. rating of Insulet (NASDAQ:PODD) on 2/23/2024 |
INTU Intuit | $630.39 +0.8% | 2/23/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $560.00 -> $585.00 | Low | View details for JPMorgan Chase & Co. rating of Intuit (NASDAQ:INTU) on 2/23/2024 |
KALU Kaiser Aluminum | $78.17 -0.2% | 2/23/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $62.00 -> $68.00 | Low | View details for JPMorgan Chase & Co. rating of Kaiser Aluminum (NASDAQ:KALU) on 2/23/2024 |
KYMR Kymera Therapeutics | $39.32 -3.1% | 2/23/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $34.00 -> $47.00 | Low | View details for JPMorgan Chase & Co. rating of Kymera Therapeutics (NASDAQ:KYMR) on 2/23/2024 |
LYV Live Nation Entertainment | $104.38 +0.6% | 2/23/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $124.00 -> $126.00 | Low | View details for JPMorgan Chase & Co. rating of Live Nation Entertainment (NYSE:LYV) on 2/23/2024 |
VAC Marriott Vacations Worldwide | $97.86 -0.8% | 2/23/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $93.00 -> $107.00 | Low | View details for JPMorgan Chase & Co. rating of Marriott Vacations Worldwide (NYSE:VAC) on 2/23/2024 |
STWD Starwood Property Trust | $20.23 +0.6% | 2/23/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $20.50 -> $21.00 | Low | View details for JPMorgan Chase & Co. rating of Starwood Property Trust (NYSE:STWD) on 2/23/2024 |
TOL Toll Brothers | $119.61 -0.6% | 2/23/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $127.00 -> $128.00 | Low | View details for JPMorgan Chase & Co. rating of Toll Brothers (NYSE:TOL) on 2/23/2024 |
VIR Vir Biotechnology | $10.68 -0.7% | 2/23/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $9.00 -> $10.00 | Low | View details for JPMorgan Chase & Co. rating of Vir Biotechnology (NASDAQ:VIR) on 2/23/2024 |
AGIO Agios Pharmaceuticals | $29.29 -2.2% | 2/23/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $31.00 -> $30.00 | Low | View details for JPMorgan Chase & Co. rating of Agios Pharmaceuticals (NASDAQ:AGIO) on 2/23/2024 |
ACRE Ares Commercial Real Estate | $7.61 -1.3% | 2/23/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $9.50 -> $8.00 | Low | View details for JPMorgan Chase & Co. rating of Ares Commercial Real Estate (NYSE:ACRE) on 2/23/2024 |
BRDG Bridge Investment Group | $6.27 -1.3% | 2/23/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $13.50 -> $11.50 | Low | View details for JPMorgan Chase & Co. rating of Bridge Investment Group (NYSE:BRDG) on 2/23/2024 |
FVRR Fiverr International | $22.04 +3.1% | 2/23/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $35.00 -> $30.00 | Low | View details for JPMorgan Chase & Co. rating of Fiverr International (NYSE:FVRR) on 2/23/2024 |
GH Guardant Health | $17.45 -1.6% | 2/23/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $60.00 -> $45.00 | Low | View details for JPMorgan Chase & Co. rating of Guardant Health (NASDAQ:GH) on 2/23/2024 |
IRTC iRhythm Technologies | $102.29 +0.2% | 2/23/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $142.00 -> $133.00 | Low | View details for JPMorgan Chase & Co. rating of iRhythm Technologies (NASDAQ:IRTC) on 2/23/2024 |
MP MP Materials | $13.05 -6.1% | 2/23/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $22.00 -> $20.00 | Low | View details for JPMorgan Chase & Co. rating of MP Materials (NYSE:MP) on 2/23/2024 |
NBIX Neurocrine Biosciences | $139.44 +0.2% | 2/23/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $154.00 -> $148.00 | Low | View details for JPMorgan Chase & Co. rating of Neurocrine Biosciences (NASDAQ:NBIX) on 2/23/2024 |
XPEV XPeng | $9.83 +2.0% | 2/23/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $19.00 -> $9.00 | Low | View details for JPMorgan Chase & Co. rating of XPeng (NYSE:XPEV) on 2/23/2024 |
ALRM Alarm.com | $72.76 -0.6% | 2/23/2024 | Target Raised by | JPMorgan Chase & Co. | - | Neutral -> Neutral | $62.00 -> $70.00 | Low | View details for JPMorgan Chase & Co. rating of Alarm.com (NASDAQ:ALRM) on 2/23/2024 |
BHVN Biohaven | $56.73 -0.6% | 2/23/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $32.00 -> $56.00 | Low | View details for JPMorgan Chase & Co. rating of Biohaven (NYSE:BHVN) on 2/23/2024 |
REPYY Repsol | $16.59 +1.4% | 2/23/2024 | Upgraded by | JPMorgan Chase & Co. | - | Neutral -> Overweight | | Low | View details for JPMorgan Chase & Co. rating of Repsol (OTCMKTS:REPYY) on 2/23/2024 |
SUM Summit Materials | $41.24 +1.0% | 2/23/2024 | Initiated by | JPMorgan Chase & Co. | - | Underweight -> Overweight | $40.00 -> $47.00 | Low | View details for JPMorgan Chase & Co. rating of Summit Materials (NYSE:SUM) on 2/23/2024 |
PEN Penumbra | $234.36 +5.5% | 2/23/2024 | Downgraded by | JPMorgan Chase & Co. | - | Overweight -> Neutral | $284.00 -> $250.00 | Low | View details for JPMorgan Chase & Co. rating of Penumbra (NYSE:PEN) on 2/23/2024 |
NTR Nutrien | $53.81 +0.1% | 2/23/2024 | Downgraded by | JPMorgan Chase & Co. | - | Neutral -> Underweight | $58.00 -> $48.00 | Low | View details for JPMorgan Chase & Co. rating of Nutrien (NYSE:NTR) on 2/23/2024 |
NIO NIO | $5.55 -0.7% | 2/23/2024 | Downgraded by | JPMorgan Chase & Co. | - | Neutral -> Underweight | $8.50 -> $5.00 | Low | View details for JPMorgan Chase & Co. rating of NIO (NYSE:NIO) on 2/23/2024 |
FLNC Fluence Energy | $14.15 +0.4% | 2/23/2024 | Upgraded by | JPMorgan Chase & Co. | - | Neutral -> Overweight | $23.00 | Low | View details for JPMorgan Chase & Co. rating of Fluence Energy (NASDAQ:FLNC) on 2/23/2024 |
BA BAE Systems | GBX 1,305 +0.8% | 2/22/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight | GBX 1,300 -> GBX 1,400 | N/A | View details for JPMorgan Chase & Co. rating of BAE Systems (LON:BA) on 2/22/2024 |
BARC Barclays | GBX 176.52 -0.2% | 2/22/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight | GBX 180 -> GBX 200 | N/A | View details for JPMorgan Chase & Co. rating of Barclays (LON:BARC) on 2/22/2024 |
RIO Rio Tinto Group | GBX 4,886 +0.5% | 2/22/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight | GBX 7,000 -> GBX 7,040 | N/A | View details for JPMorgan Chase & Co. rating of Rio Tinto Group (LON:RIO) on 2/22/2024 |
AC Air Canada | C$18.35 +0.4% | 2/22/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight | C$38.00 -> C$41.00 | N/A | View details for JPMorgan Chase & Co. rating of Air Canada (TSE:AC) on 2/22/2024 |
VRT Vertiv | $77.14 +4.0% | 2/22/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $53.00 -> $65.00 | Low | View details for JPMorgan Chase & Co. rating of Vertiv (NYSE:VRT) on 2/22/2024 |
DELL Dell Technologies | $106.61 -0.4% | 2/22/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $90.00 -> $100.00 | Low | View details for JPMorgan Chase & Co. rating of Dell Technologies (NYSE:DELL) on 2/22/2024 |
WDAY Workday | $272.60 +1.6% | 2/22/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $260.00 -> $300.00 | Low | View details for JPMorgan Chase & Co. rating of Workday (NASDAQ:WDAY) on 2/22/2024 |
RIVN Rivian Automotive | $11.40 +3.3% | 2/22/2024 | Downgraded by | JPMorgan Chase & Co. | - | Neutral -> Underweight | $20.00 -> $11.00 | Low | View details for JPMorgan Chase & Co. rating of Rivian Automotive (NASDAQ:RIVN) on 2/22/2024 |
NVDA NVIDIA | $884.55 +0.7% | 2/22/2024 | Target Raised by | JPMorgan Chase & Co. | - | Overweight -> Overweight | $650.00 -> $850.00 | Low | View details for JPMorgan Chase & Co. rating of NVIDIA (NASDAQ:NVDA) on 2/22/2024 |
CNA Centrica | GBX 129.65 -2.0% | 2/21/2024 | Reiterated by | JPMorgan Chase & Co. | - | Overweight | | N/A | View details for JPMorgan Chase & Co. rating of Centrica (LON:CNA) on 2/21/2024 |
ANTO Antofagasta | GBX 1,931.50 -0.8% | 2/21/2024 | Reiterated by | JPMorgan Chase & Co. | - | Underweight | GBX 1,320 | N/A | View details for JPMorgan Chase & Co. rating of Antofagasta (LON:ANTO) on 2/21/2024 |
VZIO VIZIO | $11.18 +0.2% | 2/21/2024 | Reiterated by | JPMorgan Chase & Co. | - | Overweight -> Neutral | $10.00 -> $11.50 | Low | View details for JPMorgan Chase & Co. rating of VIZIO (NYSE:VZIO) on 2/21/2024 |
SE SEA | $57.85 -0.5% | 2/21/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral | $42.00 -> $40.00 | Low | View details for JPMorgan Chase & Co. rating of SEA (NYSE:SE) on 2/21/2024 |
WKC World Kinect | $25.49 +2.5% | 2/21/2024 | Initiated by | JPMorgan Chase & Co. | - | Neutral | $25.00 | Low | View details for JPMorgan Chase & Co. rating of World Kinect (NYSE:WKC) on 2/21/2024 |
WEN Wendy's | $18.21 -0.7% | 2/21/2024 | Downgraded by | JPMorgan Chase & Co. | - | Overweight -> Neutral | $22.00 -> $19.00 | Low | View details for JPMorgan Chase & Co. rating of Wendy’s (NASDAQ:WEN) on 2/21/2024 |
RAPT RAPT Therapeutics | $8.33 -1.7% | 2/21/2024 | Downgraded by | JPMorgan Chase & Co. | - | Overweight -> Neutral | $35.00 -> $15.00 | Low | View details for JPMorgan Chase & Co. rating of RAPT Therapeutics (NASDAQ:RAPT) on 2/21/2024 |
SHEL Shell | GBX 2,560.50 +0.5% | 2/20/2024 | Reiterated by | JPMorgan Chase & Co. | - | Overweight | | N/A | View details for JPMorgan Chase & Co. rating of Shell (LON:SHEL) on 2/20/2024 |
AZN AstraZeneca | £102.90 0.0% | 2/20/2024 | Reiterated by | JPMorgan Chase & Co. | - | Overweight | £125 | N/A | View details for JPMorgan Chase & Co. rating of AstraZeneca (LON:AZN) on 2/20/2024 |
BP BP | GBX 491 +0.2% | 2/20/2024 | Reiterated by | JPMorgan Chase & Co. | - | Underweight | | N/A | View details for JPMorgan Chase & Co. rating of BP (LON:BP) on 2/20/2024 |
EMG Man Group | GBX 249.70 -1.7% | 2/20/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Overweight | GBX 323 -> GBX 318 | N/A | View details for JPMorgan Chase & Co. rating of Man Group (LON:EMG) on 2/20/2024 |
AAF Airtel Africa | GBX 94.45 +0.1% | 2/20/2024 | Target Lowered by | JPMorgan Chase & Co. | - | Neutral | GBX 130 -> GBX 93 | N/A | View details for JPMorgan Chase & Co. rating of Airtel Africa (LON:AAF) on 2/20/2024 |